Arbutus Biopharma Corp Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arbutus Biopharma Corp quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Arbutus Biopharma Corp Return On Assets for the quarter ending September 30, 2024 was -51.6 %, a 23.3% decline year-over-year.
  • Arbutus Biopharma Corp annual Return On Assets for 2023 was -43.4 %, a 33.1% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Assets for 2022 was -32.6 %, a 30.3% increase from 2021.
  • Arbutus Biopharma Corp annual Return On Assets for 2021 was -46.8 %, a 14% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -51.6 -9.74 -23.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -50.3 -12.3 -32.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -47.2 -12.5 -35.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -43.4 -10.8 -33.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -41.8 -9.82 -30.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38 -3.78 -11% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.7 +6.01 +14.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.6 +14.2 +30.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32 +17.3 +35.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.2 +17.8 +34.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -40.8 +11 +21.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.8 +7.63 +14% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.3 +16.1 +24.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.1 +75.7 +59.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -51.8 +59.7 +53.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54.4 +44 +44.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -65.3 +13.6 +17.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -128 -86.9 -213% Apr 1, 2020 Jun 30, 2020
Q1 2020 -111 -85.2 -325% Jan 1, 2020 Mar 31, 2020
Q4 2019 -98.5 -76.1 -340% Oct 1, 2019 Dec 31, 2019
Q3 2019 -78.9 -49.9 -172% Jul 1, 2019 Sep 30, 2019
Q2 2019 -40.8 -16.7 -68.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -26.2 +7 +21.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -22.4 +11.4 +33.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -29 +73.8 +71.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -24.2 +59.6 +71.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -33.2 +64.1 +65.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -33.8 +42.1 +55.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -103 -75.1 -271% Jul 1, 2017 Sep 30, 2017
Q2 2017 -83.8 -56.8 -210% Apr 1, 2017 Jun 30, 2017
Q1 2017 -97.4 -88.4 -990% Jan 1, 2017 Mar 31, 2017
Q4 2016 -75.9 -67.7 -830% Oct 1, 2016 Dec 31, 2016
Q3 2016 -27.8 -17.4 -169% Jul 1, 2016 Sep 30, 2016
Q2 2016 -27 -17.8 -192% Apr 1, 2016 Jun 30, 2016
Q1 2016 -8.93 +2.37 +21% Jan 1, 2016 Mar 31, 2016
Q4 2015 -8.16 +22.1 +73% Oct 1, 2015 Dec 31, 2015
Q3 2015 -10.3 +19.9 +65.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -9.23 Apr 1, 2015 Jun 30, 2015
Q1 2015 -11.3 Jan 1, 2015 Mar 31, 2015
Q4 2014 -30.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 -30.2 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.